FDA Approved: LUMRYZ — Supplemental Application (Avadel CNS Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved a supplemental application for LUMRYZ (sodium oxybate) from Avadel CNS Pharmaceuticals, LLC to support its use for narcolepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Narcolepsy

Drugs mentioned

• LUMRYZ (Sodium oxybate)

Snippet

SUPPL AP for LUMRYZ (SODIUM OXYBATE)